Compound Detail
CHEMBL572881
MOTESANIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL572881 |
| Name | MOTESANIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | RAHBGWKEPAQNFF-UHFFFAOYSA-N |
395
Targets
727
Activities
3
Assay Types
4
PK Parameters
20
Publications
3
Known Names
2
Indications
4
Mechanisms
Molecular Properties
373.5
MW (Da)
4.04
ALogP
5
HBA
3
HBD
78.9
PSA (Ų)
0.63
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Stem cell growth factor receptor inhibitor | INHIBITOR | Mast/stem cell growth factor receptor Kit | ✓ | ✓ |
| Tyrosine-protein kinase receptor RET inhibitor | INHIBITOR | Proto-oncogene tyrosine-protein kinase receptor Ret | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
| Platelet-derived growth factor receptor inhibitor | INHIBITOR | Platelet-derived growth factor receptor | ✓ | ✓ |
Indications
Carcinoma, Non-Small-Cell Lung Breast Neoplasms
Activity Summary
IC50 600 meas. best 9.03
Kd 126 meas. best 9.0
Ki 1 meas. best 8.52
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| EOL1 CHEMBL614489 | IC50 | 9.03 | 9.03 | 0.9 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 CHEMBL5749 | Kd | 9.0 | 9.0 | 1.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | Kd | 8.89 | 7.7307 | 1.3 | 15 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 8.7 | 8.7 | 2.0 | 4 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 8.52 | 8.52 | 3.0 | 5 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | Ki | 8.52 | 8.52 | 3.0 | 1 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B CHEMBL4105974 | Kd | 8.52 | 8.52 | 3.0 | 1 |
| Macrophage colony-stimulating factor 1 receptor CHEMBL1844 | Kd | 8.25 | 8.25 | 5.6 | 2 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | IC50 | 8.22 | 8.22 | 6.0 | 3 |
| Vascular endothelial growth factor receptor 2 CHEMBL3337 | IC50 | 8.22 | 8.22 | 6.0 | 1 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | IC50 | 8.1 | 8.1 | 8.0 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 CHEMBL3886 | Kd | 8.1 | 7.71 | 8.0 | 3 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | Kd | 8.04 | 8.04 | 9.1 | 2 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | Kd | 8.01 | 8.01 | 9.7 | 2 |
| Platelet-derived growth factor receptor alpha CHEMBL2007 | Kd | 8.0 | 8.0 | 10.0 | 2 |
| HUVEC CHEMBL613979 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | Kd | 7.92 | 7.92 | 12.0 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Kd | 7.85 | 7.638 | 14.0 | 5 |
| Epidermal growth factor receptor CHEMBL203 | Kd | 7.82 | 5.7563 | 15.0 | 16 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | Kd | 7.58 | 7.58 | 26.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.43 | 5.2948 | 37.0 | 21 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 7.27 | 6.0573 | 54.0 | 11 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 7.23 | 7.1533 | 59.0 | 3 |
| Tyrosine-protein kinase FRK CHEMBL4223 | Kd | 7.0 | 7.0 | 99.0 | 3 |
| Tyrosine-protein kinase Lyn CHEMBL3905 | Kd | 6.8 | 6.8 | 160.0 | 2 |
| Mitogen-activated protein kinase kinase kinase 19 CHEMBL6191 | Kd | 6.7 | 6.7 | 200.0 | 1 |
| Serine/threonine-protein kinase TNNI3K CHEMBL5260 | Kd | 6.66 | 6.66 | 220.0 | 2 |
| Epithelial discoidin domain-containing receptor 1 CHEMBL5319 | Kd | 6.58 | 6.58 | 260.0 | 2 |
| Serine/threonine-protein kinase B-raf CHEMBL5145 | Kd | 6.55 | 6.375 | 280.0 | 4 |
| Citron Rho-interacting kinase CHEMBL5579 | Kd | 6.52 | 6.52 | 300.0 | 2 |
| Tyrosine-protein kinase Lck CHEMBL258 | Kd | 6.44 | 6.44 | 360.0 | 2 |
| DU-145 CHEMBL613508 | IC50 | 6.33 | 6.33 | 469.4 | 1 |
| Ephrin type-A receptor 6 CHEMBL4526 | Kd | 6.31 | 6.31 | 490.0 | 2 |
| A204 CHEMBL614514 | IC50 | 6.29 | 6.29 | 518.5 | 1 |
| SK-N-DZ CHEMBL1075579 | IC50 | 6.26 | 6.26 | 549.0 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | Kd | 6.17 | 5.63 | 670.0 | 9 |
| CGTH-W-1 CHEMBL2366300 | IC50 | 6.17 | 6.17 | 670.0 | 1 |
| NCI-H1648 CHEMBL2366214 | IC50 | 6.16 | 6.16 | 685.6 | 1 |
| RAF proto-oncogene serine/threonine-protein kinase CHEMBL1906 | Kd | 6.06 | 6.06 | 880.0 | 2 |
| Protein-tyrosine kinase 6 CHEMBL4601 | Kd | 6.0 | 6.0 | 1000.0 | 2 |
| G-402 CHEMBL1075446 | IC50 | 5.99 | 5.99 | 1018.5 | 1 |
| Receptor-interacting serine/threonine-protein kinase 3 CHEMBL1795199 | Kd | 5.98 | 5.98 | 1044.0 | 1 |
| Serine/threonine-protein kinase 10 CHEMBL3981 | Kd | 5.96 | 5.96 | 1100.0 | 2 |
| STE20-like serine/threonine-protein kinase CHEMBL4202 | Kd | 5.89 | 5.89 | 1300.0 | 2 |
| Mitogen-activated protein kinase kinase kinase 7 CHEMBL5776 | Kd | 5.89 | 5.89 | 1300.0 | 1 |
| RT-112 CHEMBL614145 | IC50 | 5.8 | 5.8 | 1585.5 | 1 |
| Aurora kinase C CHEMBL3935 | Kd | 5.72 | 5.72 | 1900.0 | 2 |
| Mitogen-activated protein kinase kinase kinase 3 CHEMBL5970 | Kd | 5.68 | 5.68 | 2100.0 | 1 |
| Tyrosine-protein kinase Blk CHEMBL2250 | Kd | 5.66 | 5.66 | 2200.0 | 2 |
| NB10 CHEMBL2366243 | IC50 | 5.63 | 5.63 | 2350.5 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1800.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 5000.0 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 615.86 | nM | Rattus norvegicus |
| Cmax | 5623.09 | nM | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26254279 | 10.18632/oncotarget.4214 | Unchecked | 27 |
| 22037378 | 10.1038/nbt.1990 | Tyrosine-protein kinase ABL1 | 15 |
| 22037378 | 10.1038/nbt.1990 | Epidermal growth factor receptor | 12 |
| 16951187 | 10.1158/0008-5472.can-05-4665 | A-431 | 12 |
| 22037378 | 10.1038/nbt.1990 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 10 |
| 18183025 | 10.1038/nbt1358 | Epidermal growth factor receptor | 10 |
| 22037378 | 10.1038/nbt.1990 | Mast/stem cell growth factor receptor Kit | 8 |
| 22037378 | 10.1038/nbt.1990 | Receptor-type tyrosine-protein kinase FLT3 | 7 |
| 18183025 | 10.1038/nbt1358 | Tyrosine-protein kinase ABL1 | 7 |
| 16951187 | 10.1158/0008-5472.can-05-4665 | Unchecked | 7 |
| 18183025 | 10.1038/nbt1358 | Receptor-type tyrosine-protein kinase FLT3 | 5 |
| 16951187 | 10.1158/0008-5472.can-05-4665 | ADMET | 5 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| 18183025 | 10.1038/nbt1358 | Mast/stem cell growth factor receptor Kit | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22037378 | 10.1038/nbt.1990 | Proto-oncogene tyrosine-protein kinase receptor Ret | 4 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 3 |
| 22037378 | 10.1038/nbt.1990 | Hepatocyte growth factor receptor | 3 |
| 16951187 | 10.1158/0008-5472.can-05-4665 | Rattus norvegicus | 3 |
| 18183025 | 10.1038/nbt1358 | Vascular endothelial growth factor receptor 2 | 2 |
Data from ChEMBL 36 via Core Engine